X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (138) 138
humans (118) 118
male (94) 94
female (73) 73
urology & nephrology (61) 61
adult (59) 59
middle aged (54) 54
aged (36) 36
risk factors (30) 30
chronic kidney-disease (25) 25
nephrology (24) 24
animals (23) 23
kidney failure, chronic - therapy (21) 21
mexico (21) 21
rats (20) 20
chronic kidney disease (17) 17
kidney diseases (17) 17
double-blind method (16) 16
hemodialysis (16) 16
transplantation (16) 16
young adult (16) 16
hypertension (15) 15
medicine, general & internal (15) 15
diabetes (14) 14
glomerular filtration rate (14) 14
kidney transplantation (14) 14
mortality (14) 14
risk (14) 14
treatment outcome (14) 14
disease (13) 13
kidney (13) 13
prevention (13) 13
abridged index medicus (12) 12
dialysis (12) 12
follow-up studies (12) 12
retrospective studies (12) 12
adolescent (11) 11
cardiovascular diseases - prevention & control (11) 11
creatinine - blood (11) 11
cross-sectional studies (11) 11
mexico - epidemiology (11) 11
prevalence (11) 11
aged, 80 and over (10) 10
blood-pressure (10) 10
diabetes mellitus, type 2 - complications (10) 10
kidney - metabolism (10) 10
kidneys (10) 10
rats, wistar (10) 10
renal dialysis - adverse effects (10) 10
time factors (10) 10
blood pressure (9) 9
diabetes mellitus (9) 9
immunosuppressive agents - therapeutic use (9) 9
kidney - pathology (9) 9
kidney failure, chronic - complications (9) 9
mesoamerican nephropathy (9) 9
nutrition & dietetics (9) 9
risk-factors (9) 9
stage renal-disease (9) 9
cardiovascular disease (8) 8
cardiovascular diseases - etiology (8) 8
chronic kidney failure (8) 8
cohort studies (8) 8
complications (8) 8
dialysis patients (8) 8
endocrinology & metabolism (8) 8
gene expression (8) 8
gene-expression (8) 8
hyperparathyroidism, secondary - drug therapy (8) 8
nephropathy (8) 8
parathyroid-hormone (8) 8
proportional hazards models (8) 8
renal insufficiency, chronic - etiology (8) 8
renin (8) 8
albuminuria (7) 7
cardiovascular-disease (7) 7
cinacalcet hydrochloride (7) 7
dose-response relationship, drug (7) 7
end-stage renal disease (7) 7
epidemiology (7) 7
hemodialysis-patients (7) 7
hyperparathyroidism, secondary - etiology (7) 7
kidney - drug effects (7) 7
kidney - physiology (7) 7
multivariate analysis (7) 7
naphthalenes - therapeutic use (7) 7
peripheral vascular disease (7) 7
peritoneal dialysis (7) 7
peritoneal-dialysis (7) 7
population (7) 7
rheumatology (7) 7
secondary hyperparathyroidism (7) 7
severity of illness index (7) 7
survival (7) 7
analysis (6) 6
analysis of variance (6) 6
biomarkers - blood (6) 6
ckd (6) 6
creatinine (6) 6
developing countries (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Bakris, George and Correa-Rotter, Ricardo and Hou, Fan-Fan and Hou, Fanfan and Kitzman, Dalane W and Kohan, Donald and Makino, Shinya and Makino, Hirofumi and McMurray, John J V and Melnick, Joel Z and Miller, Michael G and Miller, Alan and Miller, Steven and Pergola, Pablo E and Pergola, Pablo and Perkovic, Vlado and Tobe, Sheldon and Yi, Joo Hark and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Maffei, Laura and Juncos, Luis and de Arteaga, Javier and Greloni, Gustavo and Farias, Eduardo and Zucchini, Alfredo and Vogel, Daniel and Cusumano, Ana and Santos, Juan and Fraenkel, Margaret and Gallagher, Martin and Davis, Tim and Acharya, Shamasunder and Cooke, Duncan and Suranyi, Michael and Roger, Simon and Toussaint, Nigel and Pollock, Carol and Chan, Doris and Stranks, Stephen and MacIsaac, Richard and Endre, Zoltan and Schmidt, Alice and Schmidt, Rebecca and Prager, Rudolf and Mayer, Gert and Warling, Xavier and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Costa e Forti, Adriana and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Moura Neto, Jose Andrade and Deboni, Luciane and de Lourdes Noronha, Irene and Cercato, Cintia and Prompt, Carlos Alberto and Zanella, Maria and Rassi, Nelson and D'Avila, Domingos and Milagres, Rosangela and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Amodeo, Celso and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Bajaj, Harpreet Singh and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Tam, Paul and Rabbat, Christian and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Munoz, Rodrigo and ... and SONAR Comm Investigators and SONAR Committees and Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | ENDOTHELIN | ALBUMINURIA | NEPHROPATHY | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Serum Albumin, Human - urine | Young Adult | Aged, 80 and over | Adult | Female | Diabetic Nephropathies - prevention & control | Endothelin A Receptor Antagonists - therapeutic use | Diabetic Nephropathies - urine | Glomerular Filtration Rate | Double-Blind Method | Endothelin A Receptor Antagonists - administration & dosage | Administration, Oral | Treatment Outcome | Creatinine - urine | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - prevention & control | Atrasentan - therapeutic use | Creatinine - blood | Aged | Atrasentan - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Renal Insufficiency, Chronic - urine | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Randomization | Renin | Motivation | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
by Gómez-Dantés, Héctor, MSc and Fullman, Nancy, MPH and Lamadrid-Figueroa, Héctor, PhD and Cahuana-Hurtado, Lucero, PhD and Darney, Blair, PhD and Avila-Burgos, Leticia, PhD and Correa-Rotter, Ricardo, MD and Rivera, Juan A, Prof and Barquera, Simon, Prof and González-Pier, Eduardo, PhD and Aburto-Soto, Tania, MSc and de Castro, Elga Filipa Amorin, PhD and Barrientos-Gutiérrez, Tonatiuh, PhD and Basto-Abreu, Ana C, MPH and Batis, Carolina, PhD and Borges, Guilherme, PhD and Campos-Nonato, Ismael, PhD and Campuzano-Rincón, Julio C, PhD and de Jesús Cantoral-Preciado, Alejandra, PhD and Contreras-Manzano, Alejandra G, MSc and Cuevas-Nasu, Lucia, MSc and de la Cruz-Gongora, Vanessa V, MSc and Diaz-Ortega, Jose L, MD and de Lourdes García-García, María, Prof and Garcia-Guerra, Armando, MSc and de Cossío, Teresita González, PhD and González-Castell, Luz D, MSc and Heredia-Pi, Ileana, PhD and Hijar-Medina, Marta C, PhD and Jauregui, Alejandra, MSc and Jimenez-Corona, Aida, PhD and Lopez-Olmedo, Nancy, MSc and Magis-Rodríguez, Carlos, MD and Medina-Garcia, Catalina, MS and Medina-Mora, Maria E, PhD and Mejia-Rodriguez, Fabiola, MD and Montañez, Julio C, MSc and Montero, Pablo, MS and Montoya, Alejandra, MS and Moreno-Banda, Grea L, PhD and Pedroza-Tobías, Andrea, MS and Pérez-Padilla, Rogelio, MD and Quezada, Amado D, MS and Richardson-López-Collada, Vesta L, MD and Riojas-Rodríguez, Horacio, PhD and Ríos Blancas, Maria J, MPH and Razo-Garcia, Christian, MSc and Mendoza, Martha P Romero, MD and Sánchez-Pimienta, Tania G, MSc and Sánchez-Romero, Luz M, PhD and Schilmann, Astrid, MSc and Servan-Mori, Edson, MSc and Shamah-Levy, Teresa, PhD and Téllez-Rojo, Martha M, Prof and Texcalac-Sangrador, José L, MSc and Wang, Haidong, PhD and Vos, Theo, Prof and Forouzanfar, Mohammad H, PhD and Naghavi, Mohsen, Prof and Lopez, Alan D, Prof and Murray, Christopher J L, Prof and Lozano, Rafael, Prof
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10058, pp. 2386 - 2402
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2018, Volume 20, Issue 6, pp. 1369 - 1376
Aims: Individuals with diabetes and chronic kidney disease (CKD) are at high risk for renal events. Recent trials of novel treatments have been negative,... 
diabetic kidney disease | endothelin receptor antagonist | randomized controlled clinical trial | atrasentan | personalized medicine | INHIBITION | ALBUMINURIA | PREDICTORS | HEART-FAILURE | ENDOCRINOLOGY & METABOLISM | Humans | Diabetic Nephropathies - drug therapy | Male | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - drug therapy | Drug Therapy, Combination - adverse effects | Diabetic Nephropathies - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Adult | Endothelin A Receptor Antagonists - adverse effects | Female | Diabetes Mellitus, Type 2 - complications | Drug Resistance | Endothelin A Receptor Antagonists - therapeutic use | Kidney - physiopathology | Precision Medicine | Severity of Illness Index | Kidney - drug effects | Double-Blind Method | Renal Insufficiency, Chronic - physiopathology | Disease Progression | Randomized Controlled Trials as Topic | Kidney Failure, Chronic - prevention & control | Kidney Failure, Chronic - complications | Atrasentan - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Atrasentan - adverse effects | Research Design | Type 2 diabetes | Antimitotic agents | Medical research | Endothelin | Chronic kidney failure | Diabetic nephropathies | Angiotensin | Clinical trials | Albumin | Medicine, Experimental | Antineoplastic agents | Risk factors | Creatinine | Renin | Nephropathy | Kidneys | Diabetes mellitus | Diabetes | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Patients | Index Medicus | Clinical Trial Design
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2018, Volume 20, Issue 8, pp. 1829 - 1835
Aim: The SONAR trial uses an enrichment design based on the individual response to the selective endothelin receptor antagonist atrasentan on efficacy (the... 
diabetic kidney disease | endothelin receptor antagonist | precision medicine | randomized controlled clinical trial | atrasentan | KIDNEY-DISEASE | DAPAGLIFLOZIN | ALBUMINURIA | ENDOCRINOLOGY & METABOLISM | DIABETIC-NEPHROPATHY | EMPAGLIFLOZIN | Humans | Middle Aged | Hypertension - drug therapy | Male | Risk | Renal Insufficiency - prevention & control | Renal Insufficiency - epidemiology | Drug Therapy, Combination - adverse effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Diabetic Angiopathies - complications | Endothelin A Receptor Antagonists - adverse effects | Female | Renal Insufficiency - complications | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Drug Resistance | Endothelin A Receptor Antagonists - therapeutic use | Precision Medicine | Double-Blind Method | Diabetic Angiopathies - drug therapy | Antihypertensive Agents - therapeutic use | Diabetic Nephropathies - complications | Atrasentan - therapeutic use | Hypertension - complications | Diuretics - therapeutic use | Aged | Diabetic Nephropathies - epidemiology | Angiotensin Receptor Antagonists - therapeutic use | Atrasentan - adverse effects | Albumin | Endothelin | Kidney diseases | Natriuretic peptides | Creatinine | Brain natriuretic peptide | Kidneys | Sodium | Epidermal growth factor receptors | Diabetes mellitus | Blood pressure | Diabetes mellitus (non-insulin dependent) | Patients | Glomerular filtration rate | Index Medicus | Clinical Trial Design
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 26, pp. 2482 - 2494
Journal Article
Diabetes obesity & metabolism, ISSN 1462-8902, 05/2017, Volume 19, Issue 5, pp. 749 - 753
Journal Article